[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334938-105":59,"doc-detail-334938-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cyri-b-mediated-macropinocytosis-drives-metastasis-via-lysophosphatidic-acid-receptor-uptake","CYRI-B-mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake","","Pancreatic ductal adenocarcinoma shows poor prognosis due to frequent metastasis and limited treatment options. Hyperactive KRAS drives RAC1 activation, boosting migration and proliferation while also promoting macropinocytosis. While macropinocytosis is known for nutrient scavenging, its role in trafficking signalling receptors remains unclear. CYRI-B is highly expressed in KRAS- and p53-driven pancreatic tumours, where CYRI-B loss accelerates early tumour growth but suppresses metastasis later by impairing LPA receptor 1 uptake.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cyri-b-mediated-macropinocytosis-drives-metastasis-via-lysophosphatidic-acid-receptor-uptake/334938/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cyri-b-mediated-macropinocytosis-drives-metastasis-via-lysophosphatidic-acid-receptor-uptake/334938.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main role of CYRI-B in pancreatic cancer metastasis?","Question",{"text":112,"@type":113},"CYRI-B mediates macropinocytosis-dependent uptake of lysophosphatidic acid receptor 1, which supports chemotactic migration during metastasis progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does deleting Cyrib affect tumour development and signalling?",{"text":117,"@type":113},"Deletion accelerates tumourigenesis and increases ERK and JNK-driven proliferation in precancerous lesions, suggesting CYRI-B can buffer RAC1 hyperactivation early.",{"name":119,"@type":110,"acceptedAnswer":120},"Why does CYRI-B loss eventually inhibit metastasis?",{"text":121,"@type":113},"As disease progresses, CYRI-B depletion reduces chemotactic responses to lysophosphatidic acid due to impaired macropinocytic uptake of the LPAR1 receptor.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334938,1790183344,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":41,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","RESEARCH ARTICLE  \n*For correspondence:  \n[lmm202@cam.ac.uk](lmm202@cam.ac.uk)  \nPresent address: †Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States; ‡Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom  \nCompeting interest: The authors declare that no competing interests exist.  \nFunding: See page 26  \nReceived: 26 September 2022  \nPreprinted: 24 November 2022  \nAccepted: 06 May 2024  \nPublished: 07 May 2024  \nReviewing Editor: Erica AGolemis, Fox Chase Cancer Center, United States  \n Copyright Nikolaou et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use andredistribution provided that the original author and source are credited.  \nCYRI-B-mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake  \nSavvas Nikolaou1, Amelie Juin1, Jamie A Whitelaw1, Nikki R Paul1, Loic Fort1†, Colin Nixon1, Heather J Spence1, Sheila Bryson1, Laura M Machesky1,2*‡  \n1CRUK Scotland Institute, Switchback Road, Bearsden, Glasgow, United Kingdom; 2 Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom  \n\n| Abstract Pancreatic ductal adenocarcinoma carries a dismal prognosis, with high rates of metastasis and few treatment options. Hyperactivation of KRAS in almost all tumours drives RAC1 activation, conferring enhanced migratory and proliferative capacity as well as macropinocytosis. Macropinocytosis is well understood as a nutrient scavenging mechanism, but little is known about its functions in trafficking of signalling receptors. We find that CYRI-B is highly expressed in pancreatic tumours in a mouse model of KRAS and p53-driven pancreatic cancer. Deletion of Cyrib (the gene encoding CYRI-B protein) accelerates tumourigenesis, leading to enhanced ERK and JNKinduced proliferation in precancerous lesions, indicating a potential role as a buffer of RAC1 hyperactivation in early stages. However, as disease progresses, loss of CYRI-B inhibits metastasis. CYRI-B depleted tumour cells show reduced chemotactic responses to lysophosphatidic acid, a major driver of tumour spread, due to impaired macropinocytic uptake of the lysophosphatidic acid receptor 1. Overall, we implicate CYRI-B as a mediator of growth and signalling in pancreatic cancer, providing new insights into pathways controlling metastasis. |\n| --- |\n| Editor's evaluation\u003Cbr>This important study combines in vivo and in vitro models to characterise the complex role of CYRI-B, an interactor of the small GTPase Rac1, in controlling pancreatic cancer progression towards a higher proliferative and metastatic stage. The authors demonstrate that CYRI-B reduces the typical hyperactivation of Rac1 in early stages of tumor progression; subsequently, CYRI-B mediates internalization of lysophosphatidic acid receptor 1 (LPAR1) uptake through macropinocytosis, thus regulating chemotactic migration of cancer cells towards lysophosphatidic acid (LPA) . This work, based on convincing evidence, will be of broad interest to cell biologists and the signalling research communities. |\n\nIntroduction  \nPancreatic ductal adenocarcinoma (PDAC) is highly metastatic with low survival rates and few treatment options. PDAC is thought to arise from precancerous non-invasive pancreatic intraepithelial neoplasms (PanINs) classified as PanIN1–3 depending on the molecular and histological characteristics (Hruban et al., 2001; Hruban et al., 2007) . PanINs arise from acinar cells that undergo acinar to ductal metaplasia changes (Wang et al., 2010) and as mutations accrue, PanINs progress to full PDACin which angiogenesis, infiltration of stromal cells, and invasion of the basement membrane occur as tumours progress. Metastasis is a complex process and the current gold standard mouse model of metastatic PDAC-the KPC (KRASG12D, p53R172H, Pdx-1-Cre) (Hingorani et al., 2005) recapitulates  \nNikolaou et al. eLife 2024;12:e83712. DOI: [ht","cbCaih7ms6JPYY1w","https://ap.wps.com/l/cbCaih7ms6JPYY1w","pdf",14369383,"English","# Abstract\n## Key findings\n### CYRI-B expression and tumour progression\n### CYRI-B loss and metastasis inhibition\n### LPA receptor 1 uptake via macropinocytosis\n## eLife digest overview","[{\"question\":\"What is the main role of CYRI-B in pancreatic cancer metastasis?\",\"answer\":\"CYRI-B mediates macropinocytosis-dependent uptake of lysophosphatidic acid receptor 1, which supports chemotactic migration during metastasis progression.\"},{\"question\":\"How does deleting Cyrib affect tumour development and signalling?\",\"answer\":\"Deletion accelerates tumourigenesis and increases ERK and JNK-driven proliferation in precancerous lesions, suggesting CYRI-B can buffer RAC1 hyperactivation early.\"},{\"question\":\"Why does CYRI-B loss eventually inhibit metastasis?\",\"answer\":\"As disease progresses, CYRI-B depletion reduces chemotactic responses to lysophosphatidic acid due to impaired macropinocytic uptake of the LPAR1 receptor.\"}]","CYRI-B-mediated macropinocytosis drives metastasis via lysophosphatidic acid receptor uptake | PDF",1790008930,76]